CLINICAL_TRIALS ClinicalTrials.gov record update

Clinical Investigation to Evaluate the New Health Sciences Hemanext® Oxygen Reduction System for Leukoreduced Red Blood Cells With CP2D Anticoagulant and AS-3 Additive - Pivotal Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03301779
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:40.562984+00:00
Published At: 2020-03-17T00:00:00+00:00
Record Updated At: 2020-06-23
Results Posted At: 2020-03-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Whole Blood Donation and Leukoreduction"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-06-23"
protocolSection.identificationModule.nctId: "NCT03301779"
protocolSection.identificationModule.officialTitle: "Clinical Investigation to Evaluate the New Health Sciences Hemanext\u00ae Oxygen Reduction System for Leukoreduced Red Blood Cells With CP2D Anticoagulant and AS-3 Additive - Pivotal Trial"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2020-03-17"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.